Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?

Multiple myeloma (MM) is a plasma cell malignancy that affects an increasing number of patients worldwide. Despite all the efforts to understand its pathogenesis and develop new treatment modalities, MM remains an incurable disease. Novel immunotherapies, such as CAR T cell therapy (CAR) and bispeci...

Descripción completa

Detalles Bibliográficos
Autores principales: Kegyes, David, Constantinescu, Catalin, Vrancken, Louise, Rasche, Leo, Gregoire, Celine, Tigu, Bogdan, Gulei, Diana, Dima, Delia, Tanase, Alina, Einsele, Hermann, Ciurea, Stefan, Tomuleasa, Ciprian, Caers, Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171942/
https://www.ncbi.nlm.nih.gov/pubmed/35672793
http://dx.doi.org/10.1186/s13045-022-01296-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171942/
https://www.ncbi.nlm.nih.gov/pubmed/35672793
http://dx.doi.org/10.1186/s13045-022-01296-2

Ejemplares similares